Bond Digital Health has been shortlisted for a prestigious award for its innovative Transform® data capture technology for lateral flow.
The company has been shortlisted for the Rapid Testing Innovation Award at the Advanced Lateral Flow Conference 2021 (ALFC).
Bond is one of five finalists competing for the prize, which recognises the best innovation to the field of rapid point-of-care assays or the most novel application for rapid assays during the past year.
The other finalists are:
- Atom BioWorks, Inc.
- OraSure Technologies Inc.
- University of Maryland Baltimore County & University of Maryland Baltimore
- Weavr Health
The shortlist was selected by a panel of independent judges made up of industry experts in the areas of intellectual property, capital, technology and business.
The winner, who will be chosen by an audience vote at ALFC, will receive a cash award of $10,000.
ALFC takes place in San Diego, California, from November 1-3. Bond has attended the previous two events, but this is the first time it has been shortlisted for the award.
Bond’s Commercial Director Phil Groom said:
“The Rapid Testing Innovation Award has quickly become the biggest and most prestigious prize in our industry, so it is a huge honour for us to be shortlisted.
“We’re in excellent company with some really innovative finalists, including our partners OraSure Technologies.
“Because of Covid, we’ll have to attend the event remotely this year, but we’re looking forward to virtually meeting the other finalists and attendees.”
Bond has also been shortlisted for the Medical, Life Sciences & Healthcare Award at the Made in Wales Awards.
The Awards, which take place this week in Cardiff, are organised by Wales Business Insider to celebrate the great products, innovations and ideas from companies of all sizes across Wales.
It is the second year in a row Bond has been shortlisted.